Skip to main content

Table 7 Basic clinical characteristics of selected clinical samples

From: Association between single nucleotide polymorphisms, TGF-β1 promoter methylation, and polycystic ovary syndrome

Group

CONTROL (n = 28)

IR (n = 13)

HA (n = 12)

ELSE (n = 6)

p value

Age

30 ± 4

27 ± 3

28 ± 3

30 ± 4

0.104

Height (m)

1.57 ± 0.05

1.57 ± 0.05

1.54(0.02)

1.56 ± 0.04

0.285

Weight (kg)

50.9 ± 7.2 a

59.3 ± 11.1 b

53.1 ± 2.8 a, b

48.9 ± 4.5 a

0.008

BMI

20.68 ± 2.40 a

23.92 ± 3.74 b

22.30 ± 1.27 a, b

20.03 ± 2.38 a

0.002

Testosterone (T) (nmol/L)

1.06 ± 0.42 a

1.15 ± 0.32 a

2.1 (0.69) b

1.35 (0.30) a, b

< 0.001

Fasting plasma glucose (nmol/L)

5.05 ± 0.66

5.02 ± 0.68

4.89 ± 0.63

5.32 ± 0.45

0.621

Fasting insulin (uU/ml)

9.56 ± 2.9a

19.5 ± 8.77 b

10.8 ± 2.22 a

10.18 ± 1.01a

< 0.001

Homa-IR

2.27 (0.86) a

4.51 ± 2.37 b

2.33(0.56)a, b

2.40 ± 0.24 a, b

0.002

  1. a, b: If two groups had the same marker letters, there was no statistically significant difference between them. If the two groups had different letters, the difference between them was considered statistically significant. (Hereafter, this is the same.)